AKR1B1 and hepatocellular carcinoma: Finally, the authors discovered that inhibiting AKR1B1 reduced the pathologies induced by a high fructose diet and diethylnitrosamine administration, thus supporting the role that AKR1B1 plays in mediating the glycolytic reprogramming of HCC.